1. Home
  2. ATRO vs DAWN Comparison

ATRO vs DAWN Comparison

Compare ATRO & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astronics Corporation

ATRO

Astronics Corporation

HOLD

Current Price

$66.75

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.44

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATRO
DAWN
Founded
1968
2018
Country
United States
United States
Employees
2620
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ATRO
DAWN
Price
$66.75
$21.44
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
$86.00
$26.00
AVG Volume (30 Days)
642.9K
6.4M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$158,182,000.00
Revenue This Year
$14.92
$55.03
Revenue Next Year
$8.81
$28.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.60
52 Week Low
$19.90
$5.64
52 Week High
$83.96
$21.42

Technical Indicators

Market Signals
Indicator
ATRO
DAWN
Relative Strength Index (RSI) 41.62 81.50
Support Level $47.03 $10.30
Resistance Level $82.37 N/A
Average True Range (ATR) 3.32 0.08
MACD -0.48 -0.09
Stochastic Oscillator 29.50 88.64

Price Performance

Historical Comparison
ATRO
DAWN

About ATRO Astronics Corporation

Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: